Koa Wealth Management LLC reduced its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 13.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,236 shares of the financial services provider's stock after selling 1,124 shares during the period. CME Group makes up about 1.6% of Koa Wealth Management LLC's holdings, making the stock its 21st largest position. Koa Wealth Management LLC's holdings in CME Group were worth $1,920,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in CME. Wayfinding Financial LLC acquired a new position in shares of CME Group during the 1st quarter worth $25,000. Cornerstone Planning Group LLC raised its stake in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares during the last quarter. Golden State Wealth Management LLC raised its stake in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in shares of CME Group during the 1st quarter worth $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new position in shares of CME Group during the 1st quarter worth $32,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Trading Up 0.4%
Shares of NASDAQ CME traded up $1.26 on Friday, reaching $282.21. 1,488,447 shares of the company traded hands, compared to its average volume of 2,048,058. CME Group Inc. has a fifty-two week low of $203.77 and a fifty-two week high of $290.79. The company has a 50 day moving average of $275.84 and a 200 day moving average of $266.12. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $101.70 billion, a PE ratio of 27.32, a P/E/G ratio of 5.01 and a beta of 0.44.
CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter in the previous year, the business earned $2.56 EPS. The company's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's payout ratio is currently 48.40%.
Insider Buying and Selling at CME Group
In other news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the sale, the director owned 3,108 shares in the company, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,750 shares of company stock worth $1,576,294. Company insiders own 0.30% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Morgan Stanley lifted their price target on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. UBS Group reiterated a "neutral" rating and set a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus price target of $261.93.
Get Our Latest Report on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.